Versigent PLC (VGNT) Income Statement
VGNT 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsVGNT revenue and net income
Where VGNT's revenue goes
2025Each bar shows an amount and its share of revenue. VGNT kept 6.0% of revenue as net income.
VGNT profit margins
VGNT growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +6.1% | +3.2% | — | — |
| Gross profit | +15.0% | +7.8% | — | — |
| Operating income | +25.0% | +8.9% | — | — |
| Net income | +29.4% | +5.2% | — | — |
| EPS (diluted) | +29.4% | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
VGNT quarterly EPS vs estimates
Versigent beat the analyst EPS estimate in 1 of the last 2 quarters. Next report: November 4, 2026 (estimate $1.79).
VGNT income statement
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $8.82B | $8.31B | $8.83B | $8.02B |
| Cost of revenue | $7.73B | $7.36B | $7.76B | $7.14B |
| Gross profit | $1.09B | $947.0M | $1.07B | $870.0M |
| Research & development | $274.0M | $285.0M | $273.0M | $247.0M |
| Sales, general & admin | $419.0M | $411.0M | $388.0M | $351.0M |
| Total operating expenses | $419.0M | $411.0M | $388.0M | $351.0M |
| Operating income | $670.0M | $536.0M | $687.0M | $519.0M |
| Interest income | — | — | — | $1.0M |
| Income before taxes | $540.0M | $473.0M | $596.0M | $505.0M |
| Income taxes | −$6.0M | $39.0M | $144.0M | $53.0M |
| Net income | $528.0M | $408.0M | $423.0M | $454.0M |
| EBITDA | $897.0M | $738.0M | $892.0M | $710.0M |
| EPS (diluted) | $7.43 | $5.74 | — | — |
| Gross margin | 12.3% | 11.4% | 12.2% | 10.9% |
| Operating margin | 7.6% | 6.5% | 7.8% | 6.5% |
| Net margin | 6.0% | 4.9% | 4.8% | 5.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | |
|---|---|---|---|---|---|---|---|
| Revenue | $2.44B | $2.21B | $2.30B | $2.29B | $2.21B | $2.02B | $2.13B |
| Cost of revenue | $2.12B | $1.97B | $2.03B | $1.99B | $1.94B | $1.77B | $1.86B |
| Gross profit | $321.0M | $243.0M | $270.0M | $296.0M | $263.0M | $249.0M | $269.0M |
| Sales, general & admin | $100.0M | $97.0M | $106.0M | $104.0M | $104.0M | $105.0M | $103.0M |
| Total operating expenses | $122.0M | $97.0M | $106.0M | $104.0M | $2.05B | $1.88B | $103.0M |
| Operating income | $199.0M | $146.0M | $164.0M | $192.0M | $158.0M | $144.0M | $166.0M |
| Interest income | — | $3.0M | — | — | — | $1.0M | — |
| Interest expense | $36.0M | $5.0M | — | — | $1.0M | $2.0M | — |
| Income before taxes | $157.0M | $72.0M | $115.0M | $162.0M | $130.0M | $120.0M | $142.0M |
| Income taxes | $46.0M | −$9.0M | −$110.0M | $53.0M | — | — | $8.0M |
| Net income | $118.0M | $78.0M | $217.0M | $105.0M | $107.0M | $95.0M | $127.0M |
| EBITDA | $244.0M | $207.0M | $225.0M | $296.0M | $190.0M | — | $218.0M |
| EPS (diluted) | $1.92 | $1.10 | — | — | — | — | — |
| Gross margin | 13.1% | 11.0% | 11.7% | 12.9% | 11.9% | 12.3% | 12.6% |
| Operating margin | 8.1% | 6.6% | 7.1% | 8.4% | 7.2% | 7.1% | 7.8% |
| Net margin | 4.8% | 3.5% | 9.4% | 4.6% | 4.9% | 4.7% | 6.0% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in VGNT's financial statements (latest annual report filed December 31, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.
VGNT financial results
In fiscal year 2025 (ended December 31, 2025), Versigent reported revenue of $8.8 billion, up 6.1% from the year before. It had net income of $528.0 million (up 29.4%), a net profit margin of 6.0%. Diluted earnings per share came to $7.43.
See the VGNT stock overview for the latest quote and news, or the VGNT chart for price history and technical indicators.
VGNT income statement FAQ
What is Versigent's annual revenue?
Versigent reported total revenue of $8.8 billion for fiscal year 2025, which ended on December 31, 2025. That was up 6.1% from $8.3 billion the previous year.
Is Versigent profitable?
Yes. Versigent reported net income of $528.0 million in fiscal 2025, a net profit margin of 6.0%; its operating margin was 7.6%.
What is Versigent's gross margin?
Versigent's gross margin was 12.3% in fiscal 2025: for every $100 of revenue, Versigent kept $12 after the direct cost of its products and services.
How much does Versigent spend on research and development?
Versigent spent $274.0 million on research and development in fiscal 2025, 3.1% of revenue.
What are Versigent's earnings per share?
Versigent earned $7.43 per diluted share in fiscal 2025, compared with $5.74 a year earlier.
When will Versigent report its next earnings?
Versigent is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 before the market opens.
When does Versigent's fiscal year end?
Versigent's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on December 31, 2025.